Emerg Med J 19:594-595 doi:10.1136/emj.19.6.594
  • Case report

Fatal anaphylactoid reaction to N-acetylcysteine: caution in patients with asthma

  1. A V Appelboam1,
  2. P I Dargan2,
  3. J Knighton1
  1. 1Queen Alexandra Hospital, Portsmouth, UK
  2. 2National Poisons Information Service, London, UK
  1. Correspondence to:
 Dr A Appelboam, Department of Anaesthetics, Torbay Hospital, Torquay, Devon TQ2 7AA;
  • Accepted 31 January 2002


Paracetamol overdose is a common reason for presentation to the emergency department and N-acetylcysteine is frequently used in the treatment of toxic paracetamol ingestions. Adverse reactions to N-acetylcysteine are common though usually mild and easily treated. Serious reactions to N-acetylcysteine however, are rare and there have been no previous reported fatalities with its therapeutic use. This report describes the case of a 40 year old brittle asthmatic patient who died after treatment with intravenous N-acetylcysteine. Asthma is a risk factor for adverse reactions to N-acetylcysteine and special caution should be exercised in its use in brittle asthmatic patients.


    Free sample
    This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EMJ.
    View free sample issue >>

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

    Navigate This Article